Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.
about
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionTenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence?Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionPrevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothersChronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1.Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys.Mass spectrometry in the quantitative analysis of therapeutic intracellular nucleotide analogs.Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry.Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: a focus on antiviral drugs.Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients.
P2860
Q28481276-8E4466D6-9F9B-424C-A9A8-ADDCE042E26AQ33703751-15E01197-C5EE-4C2D-BB68-937707942F49Q34481359-006287F4-6C23-48A4-9A59-FF9756BE611EQ34506545-7B4DD429-3950-44A4-BB22-627B763501F2Q34737466-02078AAE-853E-4F44-BE78-29675733F678Q35004837-8E48450C-BA84-4802-BB41-FD40663661D9Q35005051-31D22AFF-F2BF-45FF-AAA2-244A585D670CQ35077568-A84CDAF2-87AE-43A8-A4D2-D42525CD82F2Q36554980-DB87FEF8-C0CC-4D24-9D8B-69295D42785BQ36744874-C03E3C12-8D47-417C-8EC1-0BB55E598D78Q36870864-DE76050A-6E96-4013-8056-8A67F4C1621DQ37126494-01FE4D7C-4A5B-4D18-BD23-26DDDE23098BQ37347434-09C27BFB-84AD-42FD-9EA2-7BBC619F1297Q37421891-C20996A4-A8A8-4831-BA36-4886516CC73BQ37771921-8471F819-4E6C-46D8-AA73-2C4D217F73BDQ37874616-4F0DD07C-E8BD-4972-B7CF-7BA36C939F02Q38256679-93A426B2-A946-4A7C-86FD-E3F506FBA003Q39434360-DCFB069A-A21F-4621-B566-D1D7C7827E6DQ41830503-1ADEF617-8CD5-4ADD-A304-6C1D48AC998DQ46204858-3F5A474C-1B33-4F8F-843B-464FC41BFEEE
P2860
Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Evidence and possible conseque ...... tors in human red blood cells.
@en
Evidence and possible conseque ...... tors in human red blood cells.
@nl
type
label
Evidence and possible conseque ...... tors in human red blood cells.
@en
Evidence and possible conseque ...... tors in human red blood cells.
@nl
prefLabel
Evidence and possible conseque ...... tors in human red blood cells.
@en
Evidence and possible conseque ...... tors in human red blood cells.
@nl
P2093
P2860
P356
P1476
Evidence and possible conseque ...... itors in human red blood cells
@en
P2093
David Da Silva
Henri Benech
Jacques Grassi
Lucie Durand-Gasselin
P2860
P304
P356
10.1128/AAC.00831-06
P407
P577
2007-04-16T00:00:00Z